Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples